NPI: 1033684063 · NEW BRITAIN, CT 06052 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/05/2018
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/05/2018 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,191 | $56K |
| 2019 | 19,142 | $165K |
| 2020 | 15,872 | $112K |
| 2021 | 12,460 | $137K |
| 2022 | 7,151 | $144K |
| 2023 | 5,776 | $316K |
| 2024 | 2,826 | $267K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,188 | 2,278 | $759K |
| 83970 | 1,064 | 766 | $162K | |
| 82728 | 526 | 457 | $72K | |
| 83550 | 517 | 445 | $36K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 367 | 207 | $30K |
| 83540 | 518 | 446 | $30K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,803 | 800 | $28K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,951 | 1,085 | $21K |
| J1756 | Injection, iron sucrose, 1 mg | 4,182 | 1,026 | $16K |
| 82108 | 52 | 45 | $14K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 802 | 451 | $12K |
| 85041 | 1,073 | 921 | $7K | |
| A4657 | Syringe, with or without needle, each | 1,300 | 1,138 | $6K |
| 85048 | 1,069 | 919 | $5K | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 224 | 50 | $123.57 |
| G0008 | Administration of influenza virus vaccine | 84 | 74 | $69.20 |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 407 | 108 | $0.00 |
| 90662 | 14 | 13 | $0.00 | |
| J0606 | Injection, etelcalcetide, 0.1 mg | 836 | 61 | $0.00 |
| 90674 | 19 | 13 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 422 | 37 | $0.00 |